Manufacturers are starting to design functional foods, beverages and supplements that support appetite control, glycaemic balance or microbiome health all tailored to specific metabolic profiles
Two GLP-1 Strategies Helped Lock in Weight Loss The new studies, published in peer-reviewed medical journals within a day of each other, were funded by Eli Lilly, which makes the GLP-1 medications Zepbound (tirzepatide) and the oral drug Foundayo (orforglipron)
We also discuss dietary and lifestyle tips for neuropathy and look at when to seek advice from a doctor
Publicly funded research agencies like the National Institutes of Health could play an important role by rapidly investigating the most promising uses of GLP-1 drugs, particularly in areas where pharmaceutical companies may be reluctant to invest, such as traumatic brain injury, for which trials are difficult to run
How would a twice-daily oral GLP stack up commercially
Tens of thousands of people are now seeing the same thing: weight loss that feels natural, sustainable, and drama-free
)
